Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
Active, not recruiting · NCT05784012 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma | Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, laryngeal disorder, mouth disorder, neoplasm, otorhinolaryngologic disease, respiratory system disorder, squamous cell carcinoma, squamous cell neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-04 | NCT05784012 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
| Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2 |
| MFAR | 9 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Complejo Hospitalario de Navarra | Pamplona | Spain | 17 |
| Hospital Clinic de Barcelona | Barcelona | Spain | 11 |
| Hospital Clínico Universitario de Valencia | Valencia | Spain | 17 |
| Hospital Universitario 12 de Octubre | Madrid | Spain | 55 |
| Hospital Universitario Valle Hebron | Barcelona | Spain | 1 |
| Institut Catalá d'Oncologia (ICO) BADALONA | Badalona | Spain | 1 |
| Institut Catalá d'Oncologia (ICO) Hospitalet | L'Hospitalet de Llobregat | Spain | 1 |